MedPath

Effectiveness of long-acting paliperidone palmitate (PP1M) compared with oral antipsychotics on satisfaction, subjective well-being and service engagement in subjects with non-acute but symptomatic schizophrenia.

Phase 4
Completed
Conditions
schizophrenia
Registration Number
ACTRN12618001113246
Lead Sponsor
Department of Neuroscience, University of Turin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath